One week triple therapy for Helicobacter pylori: Does high-dose clarithromycin confer additional benefit?

Helicobacter

Volumn 2, Issue 4, 1997, Pages 199-204

  O'Connor, Humphrey J ^a   Loane, Joseph ^a   Bindel, Holger ^a   Bhutta, Abdul S ^a   Cunnane, Kevin ^a  

^a Tullamore General Hospital   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTITRICHOMONAL AGENT; ANTIULCER AGENT; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; DUODENUM ULCER; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; NAUSEA; PATIENT COMPLIANCE; PEPTIC ULCER; TASTE DISORDER; TIME; TREATMENT OUTCOME; TREATMENT REFUSAL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; ANTITRICHOMONAL AGENTS; CLARITHROMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; NAUSEA; OMEPRAZOLE; PATIENT COMPLIANCE; PEPTIC ULCER; TASTE DISORDERS; TIME FACTORS; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 0031298647     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.1997.tb00088.x     Document Type: Article

References (15)

1. O'Connor HJ. The role of Helicobacter pylori in peptic ulcer disease. Scand J Gastroenterol 1994; 29(Suppl 201):S11-5.
2. Goddard A, Logan R. One-week low-dose triple therapy: new standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 1995;7:1-3.
3. Bazzoli F, Zagari RM, Fossi S, Pozzato P, Alampi G, Simoni P, et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori, Eur J Gastroenterol Hepatol 1994;6:773-7.
4. Peterson WL, Graham DY, Marshall B, Blaser MJ, Genta RM, Klein PD, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol 1993;88:1860-4.
5. Van Zwet AA, Thijs JC, Roosendaal R, Kuipers EJ, Pena S, de Graaff J. Practical diagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1996;8:501-7.
6. Logan RPH, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995;36:12-6.
7. de Boer WA, Tytgat GNJ. 90% cure: which anti-Helicobacter therapy can achieve this treatment goal? Am J Gastroenterol 1995;90:1381-2.
8. Labenz J, Stolte M, Ruhl GH, Becker T, Tillenburg B, Sollbohmer M, et al. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995;7:9-11.
9. Powell KU, Bell GD, Bowden AF, Trowell JE, Jones PH. An effective one-week Helicobacter pylori eradication therapy using omeprazole, clarithromycin and metronidazole. Br J Clin Res 1995; 6:85-90.
10. Yousfi MM, El-Zimaity HMT, Al-Assi MT, Cole RA, Genta RM, Graham DY. Metronidazole, omeprazole and clarithromycin; an effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:209-12.
11. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995;7:835-40.
12. Jaup BH, Norrby A. Low dose short term triple therapy for eradication of Helicobacter pylori (abstract). Am J Gastroenterol 1994;89:1400.
13. Goddard AF, Hawkey CJ, Spiller RC. Audit of a specialised Helicobacter pylori treatment clinic (abstract). Gut 1995;37(Suppl 2):A31.
14. Lind T, Veldhuyzen van Zanten S, Unge P, Spiller R, Bayerdorffer E, O'Morain C, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH1 study. Helicobacter 1996;1:138-44.
15. Georgopoulos S, Mentis A, Karatapanis S, Mylonakis Katranis AS, Artikis V. Comparison of the efficacy of two, short-term, triple therapies based on clarithromycin, in the eradication of Helicobacter pylori (HP): a randomised study (abstract). Gut 1996;39(Suppl):A34.